PH

Paul Habermann

Hoechst Gmbh: 16 patents #180 of 4,020Top 5%
SA Sanofi-Aventis: 9 patents #154 of 1,008Top 20%
AG Aventis Pharma Deutschland Gmbh: 5 patents #71 of 418Top 20%
The General Hospital: 2 patents #806 of 3,021Top 30%
CG Consortium Für Elektrochemische Industrie Gmbh: 2 patents #59 of 219Top 30%
SA Sanofi: 1 patents #1,013 of 1,881Top 55%
WA Wacker Chemie Ag: 1 patents #641 of 1,324Top 50%
📍 Eppstein, DE: #7 of 166 inventorsTop 5%
Overall (All Time): #102,482 of 4,157,543Top 3%
34
Patents All Time

Issued Patents All Time

Showing 1–25 of 34 patents

Patent #TitleCo-InventorsDate
11230582 FGF21 variants Mark Sommerfeld, Thomas LANGER, Oliver BOSCHEINEN, Matthias Dreyer, Werner DITTRICH 2022-01-25
10660852 Expression and folding in the manufacturing process of CD-RAP by using a CD-RAP precursor protein Isabell Schoettle, Judith STOMMES, Bernd Janocha, Ursula Stillger, Eckart Bartnik +2 more 2020-05-26
9644017 Insulin derivatives having an extremely delayed time-action profile Gerhard Seipke, Roland Kurrle, Gunter Muller, Mark Sommerfeld, Norbert Tennagels +2 more 2017-05-09
8765910 Method for amidating polypeptides with basic amino acid C-terminals by means of specific endoproteases Sebastian Rissom, Christophe Salagnad, Frank Zocher, Laure Landric-Burtin 2014-07-01
8633156 Insulin derivatives having an extremely delayed time-action profile Gerhard Seipke, Roland Kurrle, Gunter Muller, Mark Sommerfeld, Norbert Tennagels +2 more 2014-01-21
8410048 Method for producing insulin analogs having a dibasic B chain terminus Frank Zocher 2013-04-02
8048854 Amidated insulin glargine Frank Zocher 2011-11-01
7939293 Method for producing carboxy-terminal-amidified peptides Heinrich Decker, Claus Lattemann, Oliver Maneg, Christophe Salagnad, Frank Zocher 2011-05-10
7638618 Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest 2009-12-29
7455987 Signal sequences for preparing leu-hirudin by secretion by E. coli into the culture medium Rudolf Bender 2008-11-25
7202059 Fusion proteins capable of being secreted into a fermentation medium Johann Ertl 2007-04-10
6875589 Mini-proinsulin, its preparation and use Michael Dorschug, Gerhard Seipke, Eugen Uhlmann 2005-04-05
6686177 Insulin analogs with enhanced zinc binding Johann Ertl, Karl Geisen, Gerhard Seipke, Axel Wollmer 2004-02-03
6534288 C peptide for improved preparation of insulin and insulin analogs Johann Ertl, Johannes Meiwes, Gerhard Seipke 2003-03-18
6531294 Preparation of pancreatic procarboxypeptidase B, isoforms and muteins thereof and their use 2003-03-11
6514730 Secretion of hirudin derivatives Gerhard Schmid 2003-02-04
6221837 Insulin derivatives with increased zinc binding Johann Ertl, Karl Geisen, Gerhard Seipke 2001-04-24
6221633 Insulin derivatives having a rapid onset of action Johann Ertl, Karl Geisen, Gerhard Seipke 2001-04-24
5919895 Secretion of hirudin derivatives Gerhard Schmid 1999-07-06
5866399 Process for inactivating carboxypeptidase Y in hirudin-containing culture broths Peter Crause, Jorg Moller, Wolfgang Ulmer 1999-02-02
5866371 Process for using the yeast ADH II promoter system for the production of heterologous proteins in high yields Werner Badziong, Joerg Moeller, Werner Aretz 1999-02-02
5616476 Synthetic isohirudins with improved stability Peter Crause, Dominique Tripier, Wolfgang Ulmer, Gerhard Schmid 1997-04-01
5538946 Hirudin derivatives with delayed action Peter Crause, Martin Paul Friedrich Kramer, Rainer Obermeier, Klaus Sauber, Dominique Tripier 1996-07-23
5496924 Fusion protein comprising an interleukin-2 fragment ballast portion Friedrich Wengenmayer 1996-03-05
5359035 Bifunctional proteins including interleukin-2 (IL-2) and granuloctyte macrophage colony stimulating factor (GM-CSF) 1994-10-25